Prothrombotic Potential of NSAID in Ischemic Heart Diesase

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|6|12|1351-1355

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.6, Iss.12, 2006-12, pp. : 1351-1355

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gene Therapy for Ischemic Heart Disease: Therapeutic Potential

By Symes J.F.  

American Journal of Cardiovascular Drugs, Vol. 1, Iss. 3, 2001-03 ,pp. : 159-166

Adis International

Access to resources Recommend Favorite

The ischemic heart—experimental models

By Ytrehus K.  

Pharmacological Research, Vol. 42, Iss. 3, 2000-09 ,pp. : 193-203

Academic Press

Access to resources Recommend Favorite

Hypertension and Ischemic Heart Disease in Women

By  

Current Pharmaceutical Design, Vol. 22, Iss. 25, 2016-07 ,pp. : 3885-3892

Bentham Science Publishers

Access to resources Recommend Favorite

To prevent, protect and save the ischemic heart: antioxidants revisited

By Andreadou Ioanna   Iliodromitis Efstathios K   Farmakis Dimitrios   Kremastinos Dimitrios Th.  

Expert Opinion on Therapeutic Targets, Vol. 13, Iss. 8, 2009-08 ,pp. : 945-956

Informa Healthcare

Access to resources Recommend Favorite

Ivabradine: The Hope for a Good Treatment of Ischemic Heart Disease

By  

Current Medicinal Chemistry, Vol. 20, Iss. 14, 2013-05 ,pp. : 1817-1823

Bentham Science Publishers

Access to resources Recommend Favorite